Conditioning and immunosuppression
| . | PBSC group . | BM group . |
|---|---|---|
| No. | 107 | 107 |
| Conditioning | ||
| Cy/TLI | 0 | 1 |
| Cy/TBI | 67 | 80 |
| Cy/TBI + other drug | 8 | 7 |
| Holoxan/TBI | 0 | 2 |
| Bu/Cy | 22 | 16 |
| Bu/Cy + other drug | 5 | 1 |
| Bu/other | 4 | 0 |
| Cy/MEA | 1 | 0 |
| ATG/OKT-3 | 25/11 | 21/16 |
| GVHD prophylaxis | ||
| CsA or MTX | 2 | 3 |
| CsA + pred | 0 | 3 |
| CsA + MMF | 2 | 0 |
| CsA + MTX | 71 | 69 |
| CsA + MTX + pred | 25 | 31 |
| CsA + pred + MMF | 3 | 0 |
| CsA + MTX + pred + MMF | 3 | 1 |
| Patients receiving G-CSF | 53* | 32 |
| Median d with G-CSF | 10 (1-24) | 11 (5-30) |
| . | PBSC group . | BM group . |
|---|---|---|
| No. | 107 | 107 |
| Conditioning | ||
| Cy/TLI | 0 | 1 |
| Cy/TBI | 67 | 80 |
| Cy/TBI + other drug | 8 | 7 |
| Holoxan/TBI | 0 | 2 |
| Bu/Cy | 22 | 16 |
| Bu/Cy + other drug | 5 | 1 |
| Bu/other | 4 | 0 |
| Cy/MEA | 1 | 0 |
| ATG/OKT-3 | 25/11 | 21/16 |
| GVHD prophylaxis | ||
| CsA or MTX | 2 | 3 |
| CsA + pred | 0 | 3 |
| CsA + MMF | 2 | 0 |
| CsA + MTX | 71 | 69 |
| CsA + MTX + pred | 25 | 31 |
| CsA + pred + MMF | 3 | 0 |
| CsA + MTX + pred + MMF | 3 | 1 |
| Patients receiving G-CSF | 53* | 32 |
| Median d with G-CSF | 10 (1-24) | 11 (5-30) |
TLI indicates total lymphoid irradiation; MMF, mycomofetilphenolate; pred, prednisolone; MEA, mitoxantrone + etoposide + arabinoside-C.
P < .01.